US10603278B2ActiveUtilityA1
Microspheres containing anthelmintic macrocyclic lactones
Est. expirySep 16, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61K 9/1617A61K 31/365A61P 33/10A61K 31/7048A61K 9/0019A61K 9/145A61K 47/28
38
PatentIndex Score
0
Cited by
8
References
10
Claims
Abstract
Disclosed are microspheres containing 1% to 20% by weight of milbemycin, avermectin or a derivative thereof, 50% to 95% by weight of a fat, a wax or a mixture thereof, 0.1% to 10% by weight of a steroid lipid, preferably cholesterol, and 0.01% to 1% by weight of an antioxidant.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. Microspheres containing 1 to 20% milbemycin, avermectin or a derivative thereof, 50% to 95% by weight of a fat or a wax or a mixture thereof, 0.1% to 10% by weight of cholesterol, and 0.01 to 1% by weight of an antioxidant, said microspheres being prepared by solubilizing said milbemycin, said avermectin or said derivative thereof, in said fat, said wax, or said mixture thereof.
2. Microspheres according to claim 1 wherein the milbemycin derivative is moxidectin, present in amounts ranging from 1 to 15%.
3. Microspheres according to claim 1 containing 60 to 90% by weight of a fat or wax or a mixture thereof.
4. Microspheres according to claims 1 , wherein the fat or wax is a fatty acid ester.
5. Microspheres according to claim 4 wherein the fat is glyceryl tristearate.
6. Microspheres according to claim 1 wherein cholesterol is present in amounts ranging from 0.1 to 5% by weight.
7. Microspheres according to claim 1 containing 0.01 to 0.5% by weight of an antioxidant.
8. Microspheres according to claim 1 wherein the diameter of the microspheres is lower than 800 μm.
9. Pharmaceutical formulations for parenteral administration, comprising the microspheres of claim 1 and an aqueous carrier suitable for parenteral administration to animals.
10. Method of preventing or treating diseases due to helminths, nematodes and endo- or ecto- parasites in warm-blooded animals with the formulations of claim 9 , said method comprising
admininstering an effective amount of said formulations to said warm-blooded animals; and
preventing or treating said diseases.Join the waitlist — get patent alerts
Track US10603278B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.